Catalyst

Slingshot members are tracking this event:

GW Pharma (GWPH) Phase 1b/2a Study Evaluating THC:CBD in Treatment of Recurrent Glioblastoma Multiforme (GBM)

Source Link:
https://www.gwpharm.com/about-us/news/gw-pharmaceuticals-plc-reports-fourth-quarter-and-year-end-2016-financial-results-and

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
GWPH
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details Update on Dec 5 2016: Data was initially expcted to be released Q4 2016. As of Dec 5,Phase 1b/2a study is completed and data is expected Q1 2017
http://ir.gwpharm.co...
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Feb 07, 2017
Occurred Source:
http://ir.gwpharm.com/releasedetail.cfm?ReleaseID=1010672
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 1b/2a, Thc:cbd, Recurrent Glioblastoma Multiforme, Gbm, Data Release
About Us
Media Center
Connect with Us
© 2025 Slingshot Insights. All rights reserved.